US Patent 10611850 Crystalline antibody formulations
Patent 10611850 was granted and assigned to Amgen on April, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 13, 2015
0
Date of Patent
April 7, 2020
0
Patent Applicant
Patent Application Number
15326316
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10611850 Crystalline antibody formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
